Familial amyloid polyneuropathy

[1]  H. Jono,et al.  Manifestations of transthyretin-related familial amyloidotic polyneuropathy: Long-term follow-up of Japanese patients after liver transplantation , 2011, Surgery Today.

[2]  Tiia Pihlamaa,et al.  Gelsolin Amyloidosis as a Cause of Early Aging and Progressive Bilateral Facial Paralysis , 2011, Plastic and reconstructive surgery.

[3]  C. Dobson,et al.  Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic peptide of apolipoprotein A-I. , 2011, Journal of molecular biology.

[4]  H. R. Bergen,et al.  Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. , 2011, Archives of neurology.

[5]  O. Suhr,et al.  Continuous development of arrhythmia is observed in swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant) , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  J. Liepnieks,et al.  Progression of transthyretin amyloid neuropathy after liver transplantation , 2010, Neurology.

[7]  Y. Ando,et al.  Transthyretin-related familial amyloidotic polyneuropathy—Progress in Kumamoto, Japan (1967–2010)— , 2010, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[8]  S. Jensen,et al.  Heart complications in familial transthyretin amyloidosis: impact of age and gender , 2010, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[9]  Y. Ando,et al.  Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients. , 2010, Archives of ophthalmology.

[10]  V. Planté-Bordeneuve,et al.  Familial amyloid polyneuropathy A clinico-pathologic study , 2009, Journal of the Neurological Sciences.

[11]  D. H. Kim,et al.  Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy , 2009, Muscle & nerve.

[12]  C. Röcken,et al.  Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene. , 2009, The Journal of molecular diagnostics : JMD.

[13]  C. Bonaïti‐pellié,et al.  Penetrance estimation of TTR familial amyloid polyneuropathy (type I) in Brazilian families , 2009, European journal of neurology.

[14]  G. Vita,et al.  Psychosocial impact of presymptomatic genetic testing for transthyretin amyloidotic polyneuropathy , 2009, Neuromuscular Disorders.

[15]  G. Sobue,et al.  The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy , 2009, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[16]  J. Kelly,et al.  Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. , 2008, Current pharmaceutical design.

[17]  O. Sandgren,et al.  Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy , 2008, Acta ophthalmologica.

[18]  M. Carvalho,et al.  Neurophysiological markers in familial amyloid polyneuropathy patients: Early changes , 2008, Clinical Neurophysiology.

[19]  C. Bonaiti-Pellié,et al.  Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[20]  F. Salvi,et al.  Gender-related risk of myocardial involvement in systemic amyloidosis , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[21]  Y. Ando,et al.  Liver Transplantation for Familial Amyloidotic Polyneuropathy (FAP): A Single‐Center Experience Over 16 Years , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  M. Benson,et al.  The molecular biology and clinical features of amyloid neuropathy , 2007, Muscle & nerve.

[23]  C. Lacroix,et al.  Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP) , 2007, Neurology.

[24]  P. Angus,et al.  Hereditary amyloidosis with progressive peripheral neuropathy associated with apolipoprotein AI Gly26Arg: Outcome of hepatorenal transplantation , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25]  D. Small,et al.  Transthyretin and familial amyloidotic polyneuropathy , 2007 .

[26]  E. Nordh,et al.  Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy , 2007, Muscle & nerve.

[27]  S. Ikeda,et al.  Transthyretin‐derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[28]  T. Tokuda,et al.  Progressive Wild‐Type Transthyretin Deposition after Liver Transplantation Preferentially Occurs onto Myocardium in FAP Patients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  J. Liepnieks,et al.  Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation , 2007, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[30]  A. Paetau,et al.  Severe ataxia with neuropathy in hereditary gelsolin amyloidosis: A case report , 2007, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[31]  M. Benson,et al.  Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides , 2006, Muscle & nerve.

[32]  B. Olofsson,et al.  Myocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathy , 2006, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[33]  N. Chastan,et al.  Cardiac conduction alterations in a French family with amyloidosis of the finnish type with the p.Asp187Tyr mutation in the GSN gene , 2006, Muscle & nerve.

[34]  M. Nishizawa,et al.  Selective silencing of a mutant transthyretin allele by small interfering RNAs. , 2005, Biochemical and biophysical research communications.

[35]  N. Heaton,et al.  Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. , 2005, The New England journal of medicine.

[36]  S. Kiuru-Enari,et al.  Cutis laxa in hereditary gelsolin amyloidosis , 2005, The British journal of dermatology.

[37]  S. Jensen,et al.  Liver Transplantation Does Not Prevent the Development of Life-Threatening Arrhythmia in Familial Amyloidotic Polyneuropathy, Portuguese-Type (ATTR Val30Met) Patients , 2004, Transplantation.

[38]  S. Ikeda,et al.  Postmortem findings in a familial amyloid polyneuropathy patient with homozygosity of the mutant Val30Met transthyretin gene , 2004, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[39]  A. Sousa,et al.  End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors , 2004, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[40]  Masaaki Nakamura,et al.  A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation , 2004, Transplantation.

[41]  B. Ericzon,et al.  Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the familial amyloidotic polyneuropathy world transplant registry , 2004, Transplantation.

[42]  C. Bonaïti‐pellié,et al.  Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families , 2003, Journal of medical genetics.

[43]  Giampaolo Merlini,et al.  Molecular mechanisms of amyloidosis. , 2003, The New England journal of medicine.

[44]  G. Said.  Familial amyloid polyneuropathy: mechanisms leading to nerve degeneration , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[45]  T. Tokuda,et al.  Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[46]  D. Booth,et al.  Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. , 2002, The New England journal of medicine.

[47]  J. Auran,et al.  Confocal Microscopy in Meretoja Syndrome , 2002, Cornea.

[48]  G. Sobue,et al.  Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. , 2002, Neurology.

[49]  M. Saraiva,et al.  Preimplantation genetic diagnosis for familial amyloidotic polyneuropathy (FAP) , 2001, Prenatal diagnosis.

[50]  M. Saraiva.  Transthyretin mutations in hyperthyroxinemia and amyloid diseases , 2001, Human mutation.

[51]  J. Kira,et al.  Suppression of transthyretin expression by ribozymes: a possible therapy for familial amyloidotic polyneuropathy , 2001, Journal of the Neurological Sciences.

[52]  M. Saraiva,et al.  Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M. , 2000, Biochemical and biophysical research communications.

[53]  G. Sobue,et al.  Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. , 1999, Brain : a journal of neurology.

[54]  A. Koeppen,et al.  Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64. , 1999, Archives of neurology.

[55]  M. Manns,et al.  Inosine(15.1) hammerhead ribozymes for targeting the transthyretin-30 mutation. , 1999, Biochemical and biophysical research communications.

[56]  O. Salonen,et al.  Gelsolin‐related spinal and cerebral amyloid angiopathy , 1999, Annals of neurology.

[57]  D. Booth,et al.  Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. , 1999, Brain : a journal of neurology.

[58]  C. Lacroix,et al.  Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy , 1998, Neurology.

[59]  N. Yanagisawa,et al.  A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. , 1998, Journal of medical genetics.

[60]  A. Negi,et al.  Ocular manifestations of familial amyloidotic polyneuropathy type I: long term follow up , 1997, The British journal of ophthalmology.

[61]  J. Buxbaum,et al.  Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. , 1997, The New England journal of medicine.

[62]  D. Horoupian,et al.  Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene , 1996, Neurology.

[63]  D. Booth,et al.  Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy , 1996, Neuromuscular Disorders.

[64]  A. Sousa,et al.  Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). , 1995, American journal of medical genetics.

[65]  A. Seppäläinen,et al.  Neuropathy in familial amyloidosis, Finnish type (FAF): Electrophysiological studies , 1994, Muscle & nerve.

[66]  G. Holmgren,et al.  Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. , 1993, Journal of medical genetics.

[67]  A. Chapelle,et al.  Gelsolin–derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187 , 1992, Nature Genetics.

[68]  S. Kiuru.  Familial amyloidosis of the Finnish type (FAF) , 1992, Acta neurologica Scandinavica.

[69]  G. Holmgren,et al.  Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP‐met30) , 1991, Clinical genetics.

[70]  M. Benson,et al.  Prenatal diagnosis of hereditary amyloidosis in a Portuguese family. , 1991, American journal of medical genetics.

[71]  C. Maury.  Immunohistochemical localization of amyloid in Finnish hereditary amyloidosis with antibodies to gelsolin peptides. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[72]  J. Kere,et al.  Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene , 1990, FEBS letters.

[73]  J. Ghiso,et al.  Mutation in gelsolin gene in Finnish hereditary amyloidosis , 1990, The Journal of experimental medicine.

[74]  R. Gregg,et al.  A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. , 1990, Genomics.

[75]  R. J. Schneider,et al.  Familial oculoleptomeningeal amyloidosis. Report of a new family with unusual features. , 1988, Archives of neurology.

[76]  G. Said,et al.  Length‐dependent degeneration of fibers in Portuguese amyloid poly neuropathy , 1984, Neurology.

[77]  J. Breslow,et al.  Isolation and characterization of the human apolipoprotein A-I gene. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[78]  H. Goren,et al.  Familial oculoleptomeningeal amyloidosis. , 1980, Brain : a journal of neurology.

[79]  P. Costa,et al.  Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[80]  R. King,et al.  Peripheral nerve changes in amyloid neuropathy. , 1974, Brain : a journal of neurology.

[81]  J. Meretoja.  Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy , 1973, Clinical genetics.

[82]  J. Meretoja.  Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. , 1969, Annals of clinical research.

[83]  P. Dyck,et al.  Dissociated sensation in amylidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies. , 1969, Archives of neurology.

[84]  M. Ohta,et al.  Polyneuritic amyloidosis in a Japanese family. , 1968, Archives of neurology.

[85]  C ANDRADE,et al.  A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. , 1952, Brain : a journal of neurology.

[86]  A. Ohtoshi,et al.  Hydrocephalus caused by conditional ablation of the Pten or beta-catenin gene , 2008, Cerebrospinal Fluid Research.

[87]  D. Small,et al.  Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. , 2007, The FEBS journal.

[88]  C. Pettersson.  Drainage of molecules from subarachnoid space to spinal nerve roots and peripheral nerve of the rat , 2004, Acta Neuropathologica.

[89]  S. Kiuru.  Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[90]  J. Herreros,et al.  Heart transplantation for Finnish type familial systemic amyloidosis. , 1997, Scandinavian cardiovascular journal : SCJ.

[91]  Sasaki Hiroyuki,et al.  Structure of the chromosomal gene for human serum prealbumin. , 1985 .

[92]  Y. Sakaki,et al.  Structure of the chromosomal gene for human serum prealbumin. , 1985, Gene.

[93]  R. Andersson.  Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. , 1976, Acta medica Scandinavica. Supplementum.

[94]  P. Dyck,et al.  Dissociated sensation in amyloidosis: compound action potentials; quantitative histologic and teased fibers; and electron microscopic studies of sural nerve biopsies. , 1968, Transactions of the American Neurological Association.